News

August 25, 2011
Genomatica Files Registration Statement for Proposed IPO
Renewable chemicals developer Genomatica announced that it has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) of shares of its common stock. Full Story

August 10, 2011
Wearable Electronics Demonstrate Promise of Brain-Machine Interfaces
Research conducted by a new member of the bioengineering faculty at the University of California, San Diego has demonstrated that a thin flexible, skin-like device, mounted with tiny electronic components, is capable of acquiring electrical signals from the brain and skeletal muscles and potentially transmitting the information wirelessly to an external computer. The development, published Aug. 12 in the journal Science, means that in the future, patients struggling with reduced motor or brain function, or research subjects, could be monitored in their natural environment outside the lab. It also opens up a slew of previously unimaginable possibilities in the field of brain-machine interfaces well beyond biomedical applications, said Professor Todd Coleman, who joined the Department of Bioengineering at the UC San Diego Jacobs School of Engineering this summer. Full Story

July 29, 2011
UC San Diego Bioengineering Startup Genomatica Tops New Biofuels Ranking
Renewable chemicals developer Genomatica recently took the #1 spot in the 2011-12 30 Hottest Companies in Renewable Chemicals and Materials rankings by BiofuelsDigest. Full Story

July 26, 2011
New UC San Diego Master Degree Program Aims to Keep the Medical Device and Medical Diagnosis Workforce Competitive
Engineers at the University of California, San Diego are launching a new graduate degree program this fall that will help medical device and medical diagnosis engineers in Southern California, and their employers, innovate and remain competitive. Full Story

June 20, 2011
Nanoparticles Disguised as Red Blood Cells Will Deliver Cancer-Fighting Drugs
Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body’s immune system and deliver cancer-fighting drugs straight to a tumor. Their research was published this week in the online Early Edition of the Proceedings of the National Academy of Sciences. Full Story

May 31, 2011
Bioengineered Medical Devices in Finals for $100K UC San Diego Entrepreneur Challenge
From hospital-borne infections that cause nearly 20,000 deaths each year to a debilitating dry eye disease that can lead to blindness, engineering students at the University of California, San Diego are developing medical devices that promise to lower costs, improve patient care and save lives. So it’s not surprising that two student teams from the UC San Diego, Jacobs School of Engineering are in the running for $100K prize as finalists in the 5th Annual UC San Diego Entrepreneur Challenge on June 1. Full Story

May 25, 2011
Nanoengineers Invent New Biomaterial That More Closely Mimics Human Tissue
A new biomaterial designed for repairing damaged human tissue doesn’t wrinkle up when it is stretched. The invention from nanoengineers at the University of California, San Diego marks a significant breakthrough in tissue engineering because it more closely mimics the properties of native human tissue. Full Story

May 24, 2011
As Gravity Wanes and Pressures Gain, It's Pain and Bane for the Brain
A group of students from the University of California, San Diego and Grossmont Community College have designed a set of experiments to precisely measure intracranial pressures in microgravity using a contraption that mimics the circulatory system of the human brain. Full Story

May 12, 2011
Southern California Wireless Health Innovators Win Funding for Inventions
Southern California researchers working on wireless health technologies recently won commercialization support and research funding through the TATRC/Qualcomm Wireless Health Innovation Challenge. The awards will support UC San Diego work on artificial retinas made from nanowires, a UCLA system that helps people re-learn to walk after a traumatic injury, and USC tools that enable doctors to monitor and modify – from afar – drugs administered by infusion pumps. Full Story

May 4, 2011
Nearly 30 Percent of New CIRM Awards go to UC San Diego Stem Cell Researchers
UC San Diego scientist garnered 8 of the total 27 of Basic Biology III awards announced today by the Independent Citizens' Oversight Committee (ICOC) of the California Institute for Regenerative Medicine. Bioengineering professor Kun Zhang from the UC San Diego Jacobs School of Engineering is among the 8 campus awardees. Full Story